EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $34,957,000 | +160.4% | 265,670 | 0.0% | 2.46% | -52.4% |
| Q3 2020 | $13,425,000 | +6.0% | 265,670 | 0.0% | 5.17% | -52.5% |
| Q2 2020 | $12,664,000 | -2.7% | 265,670 | 0.0% | 10.90% | +313.7% |
| Q1 2020 | $13,015,000 | -14.6% | 265,670 | 0.0% | 2.63% | +42.5% |
| Q4 2019 | $15,247,000 | +59.6% | 265,670 | 0.0% | 1.85% | +78.3% |
| Q3 2019 | $9,556,000 | +15.7% | 265,670 | 0.0% | 1.04% | -10.1% |
| Q2 2019 | $8,257,000 | +32.5% | 265,670 | 0.0% | 1.15% | +32.9% |
| Q1 2019 | $6,230,000 | +70.4% | 265,670 | 0.0% | 0.87% | +95.5% |
| Q4 2018 | $3,656,000 | +37.9% | 265,670 | 0.0% | 0.44% | +31.8% |
| Q3 2018 | $2,651,000 | -27.2% | 265,670 | +48.4% | 0.34% | -2.9% |
| Q2 2018 | $3,642,000 | – | 179,072 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |